The Problem with “Read and Understood” as a Training Approach
“Read and Understood” (R&U) training — where employees simply read an SOP and sign off — is pervasive in pharmaceutical manufacturing, often driven by the pressure to deploy procedures quickly. While it meets a minimal compliance checkbox, it fundamentally fails as a learning intervention.
-
Cognitive and Behavioral Impact on QC Analysts & Operators
Shallow Knowledge Retention
R&U training relies on passive reading, which is one of the least effective learning modalities. According to Edgar Dale’s Cone of Experience and adult learning theory (andragogy, Knowles, 1973), adults retain approximately 10% of what they read passively, versus 75%+ when they practice by doing. QC analysts trained only through R&U may lack procedural fluency when executing critical tasks like OOS investigations, instrument calibration, or environmental monitoring.
Normalization of Deviance
When analysts rush through R&U sign-offs without genuine comprehension, they develop procedural detachment—they follow steps mechanically without understanding the why. Diane Vaughan’s concept of the normalization of deviance (originally applied to NASA’s Challenger disaster) has been widely adapted in pharma quality literature to describe how shortcuts become culturally accepted over time. Operators begin to see non-compliance as tolerable when they’ve never been taught the risk rationale behind a step.
Reduced Critical Thinking
Critical-to-compliance tasks — such as data integrity controls, contamination prevention, and batch release decisions — require judgment, not just procedural recall. R&U training does not build the mental models needed to recognize deviations or apply procedures in novel situations. FDA’s Data Integrity Guidance (2018) and MHRA’s GxP Data Integrity Guidance (2018) both emphasize that a culture of understanding — not just documentation — is foundational to data integrity.
-
Impact on Quality Culture
Compliance vs. Quality Mindset
ICH Q10 (Pharmaceutical Quality System, 2008) explicitly states that a robust quality culture requires management commitment and employee engagement — not merely procedural compliance. When training is reduced to paperwork, it signals to the workforce that the form matters more than the substance, breeding a “tick-box” mentality. This is sometimes called “paper compliance” in regulatory literature.
Erosion of Psychological Ownership
When employees don’t understand why a procedure exists, they don’t feel accountable for its outcomes. A 2019 review in the Journal of GXP Compliance noted that sites with weak training programs showed higher rates of repeat deviations and lower CAPA effectiveness — a direct indicator of cultural disengagement.
Regulatory Scrutiny & Warning Letters
FDA Warning Letters and 483 observations frequently cite inadequate training as a root cause of GMP failures. Observations under 21 CFR 211.25, 211.68, and 211.192 commonly include language such as “personnel lack sufficient understanding” or “training was not demonstrated to be effective.” The FDA’s Quality Systems Guidance (2006) links effective training to sustainable compliance outcomes.
Cascade Effect on Investigations and CAPAs
Analysts who weren’t properly trained often cannot accurately identify deviations or articulate root causes. This undermines OOS and deviation investigations, leading to superficial CAPAs that address symptoms rather than systemic causes—a cycle well-documented in the FDA’s Pharmaceutical CGMPs for the 21st Century initiative.
-
The Rush Factor
Time pressure compounding R&U issues:
- Pressure Source
- Training Impact
- New product launches
- SOPs issued with minimal rollout time
- Regulatory deadlines
- Sign-offs prioritized over comprehension
- Staff turnover
- Onboarding compressed; critical context lost
- Audit readiness
- Training records updated reactively
This rush creates what quality professionals call a “training debt” — a growing gap between documented competency and actual capability that eventually surfaces as deviations, OOS results, or regulatory findings.
-
What Effective Training Should Look Like
Per WHO Technical Report Series No. 986, Annex 2 (2014) and PIC/S GMP Guide PE 009, Chapter 2 (Personnel), effective GMP training should include the following:
- Competency assessment (not just acknowledgment of reading)
- On-the-job training (OJT) with qualified trainers
- Periodic retraining tied to deviation trends
- Rationale-based training — explaining why, not just what
- Effectiveness evaluation through observation and testing
Key References
ICH Q10: Pharmaceutical Quality System (2008)
FDA: Pharmaceutical CGMPs for the 21st Century: A Risk-Based Approach (2004)
FDA: Data Integrity and Compliance with Drug CGMP (2018)
MHRA: GxP Data Integrity Guidance and Definitions (2018)
WHO TRS No. 986, Annex 2: WHO Good Manufacturing Practices for Pharmaceutical Products: Main Principles (2014)
PIC/S GMP Guide PE 009, Chapter 2: Personnel: Training Requirements for Pharmaceutical Manufacturers (current version)
Knowles, M.S.: The Adult Learner: A Neglected Species (1973)
Vaughan, D.: The Challenger Launch Decision: Risky Technology, Culture, and Deviance at NASA (1996)
21 CFR Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals (sections 211.25, 211.68, and 211.192)
FDA: Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations (2006)
Bottom Line
R&U training, when used as the primary or sole training method for critical GMP tasks, creates a workforce that is documentarily compliant but operationally fragile. The rush to deploy procedures without ensuring genuine understanding doesn’t just risk regulatory findings — it actively undermines the quality culture that sustainable pharmaceutical manufacturing depends on.
